PALO ALTO, Calif., March 12, 2019 /PRNewswire/ -- Cardinal Analytx Solutions, a predictive analytics company that leverages advanced machine learning solutions to improve health outcomes and reduce spend, today announced two strategic additions to its executive team: Chief Medical Officer Chris DeRienzo, MD, MPP, FAAP, and Chief Financial Officer Niall O'Cathasaigh.
"We are excited to welcome two individuals of Chris and Niall's caliber to our executive team," said Cardinal Analytx CEO Linda T. Hand. "Each brings crucial skills and experience at this pivotal point in the company's evolution as our market traction rapidly grows. The value of machine learning in transforming healthcare is clear, and both executives share in our passion for realizing this vision of delivering better care to patients sooner as fast as the market is demanding."
Recognized by Modern Healthcare in 2018 as one of 15 "Up and Comers Under 40," Dr. DeRienzo has become an international leader in the use of data science in healthcare at the intersection of humanity and technology. He has advised both state and national governments, as well as companies from early-stage ventures to the Fortune 500, on issues related to healthcare quality, safety and analytics. Prior to joining Cardinal Analytx, Dr. DeRienzo served as chief quality officer for Mission Health, an integrated delivery system based in Asheville, N.C. While there, he helped nurture a data-driven culture of continuous improvement that propelled the system back to recognition by IBM Watson as a Top 15 Health System in America in 2017 and 2018.
Board Certified in both Pediatrics and Neonatology, and still a practicing neonatologist in the Mission Children's NICU follow-up clinic, Dr. DeRienzo completed his M.D., Masters in Public Policy and post-graduate medical training at Duke University. A distinguished scholar in Stanford's Clinical Excellence Research Center, he was only the fourth medical student elected and re-elected to serve on the AMA Board of Trustees, and was appointed by the North Carolina Secretary of Health and Human Services to serve on the state's Medical Care Advisory Committee. He also is the author of "Tiny Medicine: One Doctor's Biggest Lessons from His Smallest Patients" (Big Eye Books), due in bookstores later this summer.
"Cardinal Analytx is a shining example of what data science should be – leveraging AI-enabled solutions to not only reduce cost and improve efficiency, but to measurably improve the lives of real people," said Dr. DeRienzo.
O'Cathasaigh joins Cardinal Analytx after spending 18 months as its consulting CFO. He has worked as a founder and consultant with startups and growth-stage companies in the U.S., Europe and Africa for more than 20 years. Previously he was with Countsy, an innovative professional services firm that specializes in working with venture-funded startups to provide end-to-end strategic and back office services. His experience includes work with more than 30 startups, many of which were healthcare companies, providing financial transparency and strategic guidance as well as enabling funding rounds and acquisitions. O'Cathasaigh is also a founder and partner of ManoCap, a private equity fund management company that makes equity investments in small to mid-cap enterprises in West Africa. Prior to that he worked at Apple's European divisions in Ireland and France. A qualified financial professional (CIMA), O'Cathasaigh holds a postgraduate degree in business from University College Dublin, and a joint B.A. in History and Classical Civilization from University College Galway and Universite De Poitiers.
"Healthcare AI is gaining momentum, with nearly 600 deals raising $4.3 billion in the last five years," said O'Cathasaigh. "Cardinal Analytx is well positioned in this market, with an intelligent care solution that engages payers and providers in proactively addressing health events and enabling individuals to lead healthier lives."
About Cardinal Analytx Solutions
Based in Palo Alto, Calif., Cardinal Analytx Solutions is a predictive analytics company that leverages machine learning and clinical insights to predict future risk and provide targeted clinical recommendations designed to improve patient outcomes and contain costs. The company, which was spun out of Stanford University-affiliated StartX startup accelerator, is backed by Cardinal Partners, Premera Blue Cross and the Stanford-StartX Fund. Founded by two Stanford industry professors in medicine and biomedical data science, Drs. Arnie Milstein and Nigam Shah, Cardinal Analytx is committed to transforming patient lives by combining machine learning with clinical excellence. For more information, visit www.cardinalanalytx.com or email email@example.com.
SOURCE Cardinal Analytx Solutions